| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 49.2731 | 46 |
| GSM780708 | Untreated after 4 days (C2_1) | 37.2184 | 2 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.0275 | 32 |
| GSM780719 | Untreated after 4 days (C1_2) | 39.8189 | 6 |
| GSM780720 | Untreated after 4 days (C2_2) | 42.5719 | 16 |
| GSM780721 | Untreated after 4 days (C3_2) | 48.4839 | 43 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.5057 | 34 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 50.6369 | 50 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.5449 | 39 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.3815 | 34 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.1433 | 33 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.4489 | 29 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 53.2879 | 57 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.7728 | 40 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.6835 | 16 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.2378 | 23 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.6194 | 44 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 52.9482 | 56 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.1008 | 23 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.613 | 20 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 45.453 | 29 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.3883 | 29 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 52.4816 | 55 |